Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy

NCT02705820 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Non Small Cell Lung Cancer

Interventions

DRUG: Pembrolizumab

Sponsor

Bank of Cyprus Oncology Centre

Collaborators

[object Object]